Cited by 198Tryptophan and brain disordersNeuroinflammation and Neurodegeneration MechanismsTreatment of Major Depression

Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide

Hashioka, Sadayuki, Klegeris, Andis, Monji, Akira, Kato, Takahiro, Sawada, Makoto, McGeer, Patrick L., Kanba, Shigenobu·2007·Experimental Neurology

Abstract

Circumstantial evidence has suggested that activated microglia may be associated with the pathogenesis of depression. Pro-inflammatory cytokines may also be involved. Therefore, we examined the effects of various types of antidepressants, as well as the mood-stabilizer lithium chloride, on interferon-gamma (IFN-gamma)-induced microglial production of the pro-inflammatory mediators interleukin-6 (IL-6) and nitric oxide (NO). Treatment of the murine microglial 6-3 cells with 100 U/ml of IFN-gamma resulted in an eightfold increase in IL-6 and a tenfold increase in NO into the culture medium. Pretreatment with the selective serotonin reuptake inhibitor fluvoxamine, the relatively selective noradrenaline reuptake inhibitor reboxetine, or the non-selective monoaminergic reuptake inhibitor imipramine, significantly inhibited IL-6 and NO production in a dose-dependent manner. These inhibitions were reversed significantly by SQ 22536, a cyclic adenosine monophosphate (cAMP) inhibitor, and, except for reboxetine, by the protein kinase A (PKA) inhibitor Rp-adenosine3',5'-cyclic monophosphorothioate triethylammonium salt (Rp-3',5'-cAMPS). Lithium chloride, which is believed to act by inhibiting the calcium-dependent release of noradrenaline, had a different spectrum of action on microglial 6-3 cells. It enhanced IFN-gamma-stimulated IL-6 production and inhibited NO production. The inhibitory effect of lithium chloride was not reversed by either SQ 22536 or Rp-3',5'-cAMPS. These results suggest that antidepressants have inhibitory effects on IFN-gamma-activated microglia and these effects are, at least partially, mediated by the cAMP-dependent PKA pathway. On the other hand, the mood stabilizer and anti-manic agent lithium chloride has mixed effects on IFN-gamma-induced microglial activation.

Integrity signals

Registry

Crossref · 10.1016/j.expneurol.2007.03.022

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., McGeer, P. L., & Kanba, S.
Affiliations
  • Kyushu University (JP)
  • University of British Columbia (CA)
  • Research Institute of Environmental Medicine, Nagoya University (JP)
Corresponding author
  • Hashioka, Sadayuki
  • Monji, Akira
Venue
Experimental Neurology
Publisher
Elsevier BV
Published
2007-07
Volume
206
Issue
1
Pages
33-42
ISSN
0014-4886 (ISSN-L)
OpenAlex
W1970022478
Cited by
198
References
42
Citations by year
2026: 3 · 2025: 3 · 2024: 7 · 2023: 4 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 10 · 2018: 5 · 2017: 7 · 2016: 18 · 2015: 16 · 2014: 18 · 2013: 14 · 2012: 18
FWCI
3.53
Type
journal article
Language
en
Open access
closed
Locations
  • Experimental Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
antidepressants, microglia, interferon-gamma, interleukin-6, nitric oxide, fluvoxamine, reboxetine, imipramine, lithium chloride, cAMP signaling, protein kinase A, microglial activation, depression, inflammatory cytokines, mood stabilizers
MeSH terms
Cyclic AMP, Animals, Antidepressive Agents, Antiviral Agents, Brain, Cell Line, Depressive Disorder, Dose-Response Relationship, Drug, Enzyme Inhibitors, Interferon-gamma, Mice, Inbred C57BL, Nitric Oxide, Neurotransmitter Uptake Inhibitors, Interleukin-6, Up-Regulation, Microglia, Cyclic AMP-Dependent Protein Kinases, Lithium Chloride, Antimanic Agents, MAP Kinase Signaling System, Mice, Cyclic AMP-Dependent Protein Kinase Type II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review